(33 days)
Not Found
No
The document describes a laboratory control material for protein analysis and does not mention any AI or ML components.
No
The device is described as an "accuracy and precision assayed control" for use in determining human serum proteins, indicating it is for diagnostic testing rather than directly treating a condition.
No
This device is a control for accuracy and precision in the determination of human serum proteins, not a device that directly diagnoses a medical condition.
No
The device description explicitly states it is a "liquid control prepared from human serum with stabilizers and preservative," indicating it is a physical substance, not software.
Yes, this device is an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that the controls are for use in the "determination of the following human serum proteins" using specific laboratory methods (immunonephelometry and immunoturbidimetry). This indicates the device is used to analyze biological samples (human serum) to provide information about a patient's health status.
- Device Description: The description confirms it's a "liquid control prepared from human serum" and is intended to be used as an "accuracy and precision control" for the analysis of human serum proteins. This further supports its role in a diagnostic testing process.
- Predicate Device: The mention of a predicate device (N/T Protein Control OL (K002002)) which is likely also an IVD, strengthens the classification of this device as an IVD.
The device is a control material used in vitro (outside the body) to ensure the accuracy and precision of diagnostic tests performed on human serum samples. This aligns perfectly with the definition of an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
N/T Protein Controls SL/L, M, and H are for use as accuracy and precision assayed controls in the determination of the following human serum proteins by immunonephelometry with BN™ Systems: IgG, IgG7, IgA, IgM, C3c, C4, Transferrin, in Innonophobionou y ma2-macroglobulin, Haptoglobin, α--acid glycoprotein, Prealbumin, Albumin, c.y antill Jpon) @2 maor J.g/L-chain lambda & kappa, β2-microglobulin, soluble Transferrin Receptor (STFR), Ferritin, IgE, and Total protein; and by immunoturbidimetry with the TurbiTimeSystem: IgG, IgA, IgM, C3c, C4, Transferrin, Albumin, Haptoglobin, α4acid glycoprotein.
Product codes (comma separated list FDA assigned to the subject device)
JJY
Device Description
N/T Protein Control SL is a liquid control prepared from human serum with sfabilizers and preservative. It is intended to be used as an accuracy and precision control for the presentation of human serum proteins by immunonephelometry with BN™ Systems and by immunoturbidimetry with the TurbiTimeSystem.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
human serum
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Stability was evaluated according to Dade Behring protocols and the control was found to Stablity was evaluation as overling to D to +8° C, as originally packaged and for at least 14 days at +2° to +8° C, once opened.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 862.1660 Quality control material (assayed and unassayed).
(a)
Identification. A quality control material (assayed and unassayed) for clinical chemistry is a device intended for medical purposes for use in a test system to estimate test precision and to detect systematic analytical deviations that may arise from reagent or analytical instrument variation. A quality control material (assayed and unassayed) may be used for proficiency testing in interlaboratory surveys. This generic type of device includes controls (assayed and unassayed) for blood gases, electrolytes, enzymes, multianalytes (all kinds), single (specified) analytes, or urinalysis controls.(b)
Classification. Class I (general controls). Except when intended for use in donor screening tests, quality control materials (assayed and unassayed) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.
0
SEP = 4 2001
510(k) Summary For N/T Protein Control SL
Manufacture's Name, Address, Telephone, and Contact Person, Date of 1. Preparation:
Manufacturer:
Dade Behring Marburg GmbH Emil-von-Behring Str. 76 Marburg/Germany
Contact Information:
Dade Behring Inc. Glasgow Site P.O. Box 6101 Newark, Delaware 19714 Attn: Rebecca S. Ayash Tel: 302-631-6276
Preparation date:
July 31, 2001
Device Name/ Classification: 2.
N/T Protein Control SL:
Quality Control Material (assayed)
Classification Number:
Class I (862.1660)
Identification of the Legally Marketed Device: 3.
N/T Protein Control SL (K002852)
Device Description: 4.
N/T Protein Control SL is a liquid control prepared from human serum with sfabilizers and preservative. It is intended to be used as an accuracy and precision control for the presentation of human serum proteins by immunonephelometry with BN™ Systems and by immunoturbidimetry with the TurbiTimeSystem.
5. Device Intended Use:
N/T Protein Controls SL/L, M, and H are for use as accuracy and precision assayed controls in the determination of the following human serum proteins by immunonephelometry with BN™ Systems: IgG, IgG7, IgA, IgM, C3c, C4, Transferrin, in Innonophobionou y ma2-macroglobulin, Haptoglobin, α--acid glycoprotein, Prealbumin, Albumin, c.y antill Jpon) @2 maor J.g/L-chain lambda & kappa, β2-microglobulin, soluble Transferrin Receptor (STFR), Ferritin, IgE, and Total protein; and by immunoturbidimetry with the TurbiTimeSystem: IgG, IgA, IgM, C3c, C4, Transferrin, Albumin, Haptoglobin, α4acid glycoprotein.
Image /page/0/Picture/22 description: The image shows the word "CONFIDENTIAL" in large, bold, black letters. The letters are closely spaced and fill most of the frame. The background is plain white, providing a stark contrast to the bold text.
000027
1
Medical device to which equivalence is claimed and comparison information: 6.
The modified N/T Protein Control SL is substantially equivalent in intended use to N/T The modified NYT T Totell Control SE to Sassianaly Se Sales N/T Control SL, like the Protein Control OL (K002002) ourrolly marketsused as quality control material to current NYT Frotein Oontrol OE is interface to be accuracy in BN™ Systems and the TurbiTimeSystem.
Device Performance Characteristics: 7.
Stability:
Stability.
Stability was evaluated according to Dade Behring protocols and the control was found to Stablity was evaluation as overling to D to +8° C, as originally packaged and for at least 14 days at +2° to +8° C, once opened.
2
Image /page/2/Picture/1 description: The image shows the seal of the U.S. Department of Health & Human Services. The seal features an abstract image of an eagle with three lines representing its wings. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle.
Food and Drug Administration 2098 Gaither Road Rockville MD 20850
SEP = 4 2001
Ms. Rebecca S. Ayash Director, Regulatory Affairs Dade Behring, Inc. Glasgow Site, PO Box 6101 Newark, DE 19714
K012468 Re:
Trade/Device Name: N/T Protein Control SL Regulation Number: 21 CFR 862.1660 Regulatory Class: I, reserved Product Code: JJY Dated: July 31, 2001 Received: August 2, 2001
Dear Ms. Ayash:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Good Manufacturing Practice for Medical Devices: General (GMP) regulation (21 CFR Part 820) and that, through periodic GMP inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
3
Page 2 -
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and v additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4588. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely yours,
Steven Sutman
Steven I. Gutman, M.D., M.B.A. Director Division of Clinical Laboratory Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Dade Behring Inc.
N/T Protein Control SL
510(k) Notification
Indications for Use Statement
N/T Protein Control SL Device Name:
Indications for Use:
N/T Protein Controls SL/L, M, and H are for use as accuracy and precision N/ 1 Toteln Controls of the following human serum proteins by immunonephelometry with BN™ Systems: IgG, IgG14, IgA, IgM, C3c, C4, immanonopholomosiy wantitrypsin, α2-macroglobulin, Haptoglobin, α;-acid Translermir, Albumin, or antilippensin, Ceruloplasmin, RbP, Ig/L-chain lambda & giyooprotein, 1 Toalbumin, Huble Transferrin Receptor (STTR), Ferritin, IgE, and Kappa, p2-morogiobailin, obluble idimetry with the TurbiTimeSystem: IgG, IgA, IgM, C3c, C4, Transferrin, Albumin, Haptoglobin, α+-acid glycoprotein.
(PLEASE DO NOT WRITE BELOW THIS LINE -- CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use (Per 21 CFR 801.109)
Over-The-Counter-Use (Optional Format 1-2-96)
Kesia Alexander for Liam Cooper
(Division Sign-Off)
510(k) Number
000025